Related Experiment Videos
Anagrelide: a potent and selective inhibitor of platelet cyclic AMP phosphodiesterase enzyme activity
1Preclinical Cardiovascular Research Bristol-Myers Company, Wallingford, CT 06492-7660.
Biochemical Pharmacology
|July 15, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
"Hands off hand hygiene training": Implementation of a COVID safe auditor training program.
American journal of infection control·2022
Adenosine triphosphate bioluminescence to validate decontamination of endoscopes.
The Journal of hospital infection·2017
A bundle of care to reduce colorectal surgical infections: an Australian experience.
The Journal of hospital infection·2011
Adverse events related to medications identified by a Canadian poison centre.
Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique·2011
Recent advances in Tumor microenvironment-responsive pro-antibody to overcome on-target, off-Tumor toxicity.
Biochemical pharmacology·2026
Design, synthesis, and biological evaluation of pyrimidine linked fused thiazole-isoxazole conjugates as dual cholinesterase inhibitors for Alzheimer's disease.
Zeitschrift fur Naturforschung. C, Journal of biosciences·2026
Motif-Selective DNA Recognition and Promoter-Dependent Transcriptional Repression by a Cyclic Pyrrole/Lysine Polyamide.
Chembiochem : a European journal of chemical biology·2026
Macrocyclization of ω-Isocyano Aldehydes.
Angewandte Chemie (International ed. in English)·2026